Study Finds Sequencing Circulating DNA Can Detect Heart Transplant Rejection Earlier than Biopsies
March 29, 2011
Study Finds Sequencing Circulating DNA Can Detect Heart Transplant Rejection Earlier than Biopsies
Stanford researchers found that sequencing can not only detect the DNA from a donated organ in the recipient's blood, but can also detect spikes in the proportion of donor DNA, which is indicative of transplant rejection.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quake Group Issued Patent for Detection of Fetal Aneuploidy with Next-Gen Sequencing
August 31, 2011 / Clinical Sequencing News - NIPT Developers Consider Sub-Chromosomal Alterations
May 1, 2013 / Clinical Sequencing News - Verinata Licenses Quake Patent, Setting Stage for IP Tussle with Sequenom
September 7, 2011 / Clinical Sequencing News - Building on Trisomy 21 Test, Hong Kong Team Develops Method to Detect T13 and T18
July 6, 2011 / Clinical Sequencing News - TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
June 29, 2011 / Clinical Sequencing News